Lobbying Arrangements: Pharmacy
New Lobbying Registrations About Pharmacy By Quarter
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details FDA Approval of generic mifepristone and related Risk Evaluation Mitigation Strategies (REMS). VA rulemaking on providing abortion services to veterans. Issues related to medication abortion. Issue... |
GenBioPro, Inc.
|
EMERGENT STRATEGIES | |||
Details S.2624, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2024 (issues related to funding for the community health center program, the Nationa... |
ADVOCATES FOR COMMUNITY HEALTH
|
in-house lobbying | |||
Details Support Act |
DisposeRx
|
Frost Brown Todd LLC | |||
Details Client is an Investor in the infrastructure of the United States, he runs both an investment group, as well as a international sports team, and deals with a multitude of issues related to his many ... |
Amir Allahverdi
|
MICHAEL ROTHSCHILD | |||
Details Issues related to the Biologics Price Competition and Innovation Act of 2009. Issues related to FDA user fee legislation, including S. 4348, the Food and Drug Administration Safety and Landmark Adv... |
Boehringer Ingelheim Pharmaceuticals, Inc.
|
Sims Strategies, LLC | |||
Details Federal Research Assistance for Technology Development of Pharmaceutical Production |
Accelbeam Photonics LLC
|
The Bennett Consulting Group | |||
Details H.R.1770 - Equitable Community Access to Pharmacist Services Act; PBM reform; PREP Act authorities |
National Association of Chain Drug Stores
|
Prime Policy Group | |||
Details Prescription drug payment reform. Supply Chain. Strategic National Stockpile. 340B. |
Gilead Sciences, Inc.
|
Todd Strategy Group | |||
Details Issues related to pharmaceutical industry, generally |
Pharmaceutical Research and Manufacturers of America
|
RICCHETTI INCORPORATED | |||
Details Issues related to regulatory and legislative developments regarding biosimilars. |
Boehringer Ingelheim Pharmaceuticals, Inc.
|
alb solutions | |||
Details H.R. 7047, Lowering Costs by Improving Biosimilar Uptake Act |
Boehringer Ingelheim Pharmaceuticals, Inc.
Pharmaceutical company |
KING & SPALDING LLP | |||
Details Issues related to supply chain management and drug pricing |
Cencora, Inc. (Formerly AmerisourceBergenCorporation)
|
OXFORD STRATEGIES | |||
Details Issues related to drug pricing and general healthcare issues |
Mallinckrodt LLC
|
OXFORD STRATEGIES | |||
Details Issues related to HR 1996 and S.910, the Safe Banking Act. |
Scott's Miracle-Gro
|
FULCRUM PUBLIC AFFAIRS LLC | |||
Details Issues related to compounding medications, including safety and supply chain issues. |
Empower Pharmacy
|
Faegre Drinker Biddle & Reath LLP | |||
Details H.R. 7047, Lowering Costs by Improving Biosimilar Uptake Act |
Boehringer Ingelheim Pharmaceuticals, Inc.
Pharmaceutical company |
KING & SPALDING LLP | |||
Details Capping Medicare Part D Out of Pocket Costs; Smoothing Medicare Part D Out of Pocket Costs; Medicare Part B and Part D drug pricing; Part D patient protections; Medicare quality measures for long-t... |
Alliance for Aging Research
|
Venable LLP | |||
Details ACA coverage for all adult vaccines (regulation related to Public Health Service Act, Sec 2713); Appropriations related to CDC report on arbovirus threat; Appropriations related to funding the Stat... |
VALNEVA USA, INC.
|
in-house lobbying | |||
Details Issues related to implementation of the drug pricing provisions of the Inflation Reduction Act of 2022. S.2305 - Biosimilar Red Tape Elimination Act - in support. S. 2157 - A bill to repeal prescri... |
New Venture Fund
|
PORT SIDE STRATEGIES, LLC | |||
Details Issues related to government involvement in the development of COVID-19 therapies |
Pardes Biosciences, Inc.
|
RICCHETTI INCORPORATED | |||
Details Funding for oral antivirals for covid. Physician prescribing of covid antivirals Medicare coverage of oral antivirals NIH funding for clinical trials |
Pardes Biosciences, Inc.
|
in-house lobbying | |||
Details Issues related to overdose reversal products; H.R.2617, Consolidated Appropriations Act, 2023 (P.L.117-328) implementation; FY2024 Departments of Labor, Health and Human Services, and Education, an... |
Indivior Inc.
|
Crossroads Strategies, LLC | |||
Details Strategy development and implementation of federal government relations initiatives relating to phospholine iodide issues with the Food and Drug Administration and Centers for Medicare and Medicaid... |
Fera Pharmaceuticals, LLC
|
BUCHANAN INGERSOLL & ROONEY PC | |||
Details Federal Trade Commission - antitrust issues related to PBMs FTC inquiry into competitive market for PBMs |
The Pharmaceutical Care Management Association
|
Bose Public Affairs Group | |||
Details Federal Trade Commission - antitrust issues related to PBMs FTC inquiry into competitive market for PBMs |
The Pharmaceutical Care Management Association
|
Bose Public Affairs Group | |||
Details Introduction to Prime to new Members of the 118th Congress Monitoring PBM Legislation Senate Finance Committee PBM Framework - Delinking S.1339 - The Pharmacy Benefit Manager Reform - Delinking H.R... |
Prime Therapeutics
|
STUMPTOWN STRATEGIES | |||
Details Federal contracts for biopharmaceuticals development. |
SAb Biotherapeutics, Inc.
|
DLA Piper LLP (US) | |||
Details Issues related to higher education, entrepreneurship and innovation center, emergency preparedness, accessibility issues, and appropriations. Staff Assistant, Legislative Correspondent, Legislative... |
The University of Louisiana Monroe Foundation
|
Cornerstone Government Affairs, Inc. | |||
Details Safe step act, help copays act, chronic disease education and awareness program at CDC. CDC chronic disease education and awareness program - appropriations! Inflation Reduction Act and Part D out ... |
NATIONAL PSORIASIS FOUNDATION
|
in-house lobbying | |||
Details Issues related to the regulation of cannabis and CBD Research and development of cannabis-derived therapies SAFE Banking Act 2023 |
Jazz Pharmaceuticals, Inc.
Pharmaceutical manufacturing and healthcare. |
in-house lobbying |